Cantargia AB (Publ) (Nasdaq Stockholm:CANTA) today reported that the rationale and study design of the phase 1b/2 clinical trial investigating nadunolimab in combination with immune-checkpoint ...
Clinical site selection platform RyghtAI has launched a search engine designed to give drug developers and contract research ...
The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...
3d
Replimune Group (REPL) Is Down 75.0% After FDA Rejects RP1 Melanoma BLA Over Trial Design Concerns
In April 2026, Replimune Group received a complete response letter from the FDA for its BLA seeking approval of RP1 plus nivolumab for advanced melanoma, despite earlier breakthrough therapy ...
The creation of JAMA+ Trials, a new online platform attesting to the vision, innovation, and resilience represented by clinical trial research is discussed in an editorial. On this platform, readers ...
Design and optimize cardiometabolic trials by addressing complexity, endpoints, recruitment, and regulatory requirements.
Three world-leading key opinion leaders, researchers and clinicians, join Clinical Advisory Board, reinforcing Bioxodes’ global registrational clinical strategy Positive ongoing discussions with ...
Design Therapeutics, Inc. announced the initiation of a Phase 1 clinical trial for its gene-targeted treatment DT-216P2 in healthy volunteers, with patient dosing for Friedreich Ataxia (FA) set to ...
Post-thrombotic syndrome is common after deep-vein thrombosis and can cause severe symptoms involving the limbs that impair patients’ activity and quality of life. Endovascular therapy can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results